营养咨询和地中海饮食在上腺瘤缩症:一个现实生活经验
Maria Rita Spreghini1, Nicoletta Gianni2, Tommaso Todisco1,3
1UOC of Endocrinology and Diabetology, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, IRCCS, 00165 Rome, Italy.
Nutrients
|October 16, 2024
概括
一种非常长链脂肪酸 (VLCFA) 限制的饮食显著降低了VLCFA水平,患者和携带者与上腺白细胞缩 (X-ALD). 这种饮食方法是有效的,应该鼓励作为X-ALD的辅助治疗.
科学领域:
- 生物化学 生物化学
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
背景情况:
- 腺核性白细胞缩 (X-ALD) 是一种代谢障碍,其特征是非常长链脂肪酸 (VLCFA) 的过氧体β氧化受损.
- 积累VLCFA导致逐渐脱髓化和上腺功能不充分.
研究的目的:
- 评价限制VLCFA的地中海饮食在降低X-ALD患者和携带者的血VLCFA水平方面的有效性.
- 评估饮食的坚持及其对VLCFA水平及其相关比率的影响.
主要方法:
- 在36名X-ALD患者和20名携带者中,对血VLCFA水平的回顾性分析.
- 基线 (T0) 和1年 (T1) VLCFA水平的比较,包括C26:0和C26:0/C22:0的比率,符合标准的人与不符合标准的人.
- 评估甘油三和胆固醇水平.
主要成果:
- 符合标准的成年患者与不符合标准的患者相比,C26:0水平和C26:0/C22:0比率显著降低.
- 在符合标准的成年患者中,从基线到T1.1,观察到C26:0,C26:0/C22:0比率和胆固醇的显著降低.
- 与非合规航空公司相比,合规航空公司的C26:0/C22:0比率较低,C26:0/C22:0和C24:0/C22:0比率从T0到T1.0显著下降.
结论:
- 限制VLCFA的饮食是一种有效的干预措施,可以降低X-ALD患者的血VLCFA水平和相关比率.
- 该研究强烈建议鼓励这种饮食方法作为X-ALD管理的既定治疗方法的辅助.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


